GlassScriptPhysician profile
Casey J Jones
NPI 1194429043
$3,275.99
in general payments reported to CMS, 2019-2025
27 companies · $356 in 2025
The $356 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,751 · 2024: $1,169 · 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,027 · Travel and Lodging: $1,249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,027.35 |
| Travel and Lodging | $1,248.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $805.64 | 2023 | Xlif |
| Inspire Medical Systems, INC. | $565.55 | 2023-2024 | Inspire |
| Edwards Lifesciences Corporation | $298.24 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Idorsia Pharmaceuticals US INC | $177.24 | 2023-2024 | Quviviq |
| Jazz Pharmaceuticals INC. | $167.68 | 2023 | |
| Madrigal Pharmaceuticals | $148.21 | 2024 | Rezdiffra, Resmetirom |
| Amgen INC. | $139.48 | 2025 | |
| Axsome Therapeutics, INC. | $117.72 | 2025 | Auvelity |
| Novo Nordisk INC | $109.00 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $95.09 | 2024 | Lifevest |
| Harmony Biosciences LLC | $91.96 | 2023-2025 | Wakix |
| Philips North America LLC | $82.63 | 2023-2024 | (Ak6) Vest Therapy |
| Corium, LLC | $73.47 | 2023-2024 | Azstarys |
| Scpharmaceuticals INC. | $63.26 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $59.08 | 2023-2024 | Breztri, Farxiga, Airsupra |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $44.08 | 2023 | Optimizer |
| Mallinckrodt Hospital Products INC. | $28.98 | 2023 | Acthar |
| Takeda Pharmaceuticals U.S.A., INC. | $24.58 | 2024 | Glassia |
| Merck Sharp & Dohme LLC | $23.34 | 2024 | Verquvo |
| Ardelyx, INC. | $22.16 | 2025 | Ibsrela |
| Tonix Medicines, INC. | $22.00 | 2025 | Tonmya |
| Medtronic, INC. | $21.87 | 2023 | Sonicision |
| Abbvie INC. | $21.47 | 2024 | |
| Novartis Pharmaceuticals Corporation | $20.92 | 2023 | Leqvio |
| Lilly USA, LLC | $19.59 | 2025 | Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.70 | 2023 | Ofev |
| Sanofi-Aventis U.S. LLC | $16.05 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.